-
Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC et al DC
- 1:17-cv-01614
- D. Del.
- Filed: 11/09/2017
- Closed: 01/23/2019
- Latest Docket Entry: 01/23/2019
- Judge: Mitchell S. Goldberg
+1
- PACER
1
Plaintiff
6
Defendants
2
Accused
Products
4
Patents-in-Suit
441
Days in
Litigation
-
Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC et al DC
- 1:17-cv-01614
- D. Del.
- Filed: 11/09/2017
- Closed: 01/23/2019
- Latest Docket Entry: 01/23/2019
- Judge: Mitchell S. Goldberg
+1
- PACER
Causes of Action
Infringement
Declaratory Judgment
Patent Infringement
Patent Non-Infringement
Patent Non-Infringement
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
-
Infringement
Actavis Elizabeth LLC
- 4 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Version of DORYX MPC | US 6,958,161 B2 | All Asserted Claims |
Infringement
Entry 86
|
| Generic Version of DORYX MPC | US 9,295,652 B1 | All Asserted Claims |
Infringement
Entry 86
|
| Generic Version of DORYX MPC | US 9,446,057 B2 | All Asserted Claims |
Infringement
Entry 86
|
| Generic Version of DORYX MPC | US 9,511,031 B2 | All Asserted Claims |
Infringement
Entry 86
|
Lupin Atlantis Holdings SA
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| doxycycline hyclate product 120 mgdoxycycline hyclate product 60 mg | US 9,295,652 B1 | All Asserted Claims |
Infringement
Entry 97
|
| doxycycline hyclate product 120 mgdoxycycline hyclate product 60 mg | US 9,446,057 B2 | All Asserted Claims |
Infringement
Entry 97
|
| doxycycline hyclate product 120 mgdoxycycline hyclate product 60 mg | US 9,511,031 B2 | All Asserted Claims |
Infringement
Entry 97
|
Lupin Pharmaceuticals Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| doxycycline hyclate product 120 mgdoxycycline hyclate product 60 mg | US 9,295,652 B1 | All Asserted Claims |
Infringement
Entry 97
|
| doxycycline hyclate product 120 mgdoxycycline hyclate product 60 mg | US 9,446,057 B2 | All Asserted Claims |
Infringement
Entry 97
|
| doxycycline hyclate product 120 mgdoxycycline hyclate product 60 mg | US 9,511,031 B2 | All Asserted Claims |
Infringement
Entry 97
|
Teva Pharmaceutical Europe BV
- 4 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Version of DORYX MPC | US 6,958,161 B2 | All Asserted Claims |
Infringement
Entry 86
|
| Generic Version of DORYX MPC | US 9,295,652 B1 | All Asserted Claims |
Infringement
Entry 86
|
| Generic Version of DORYX MPC | US 9,446,057 B2 | All Asserted Claims |
Infringement
Entry 86
|
| Generic Version of DORYX MPC | US 9,511,031 B2 | All Asserted Claims |
Infringement
Entry 86
|